Agios Pharmaceuticals
AGIO
#5110
Rank
HK$13.38 B
Marketcap
HK$225.05
Share price
-0.55%
Change (1 day)
-16.67%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: HK$13.38 Billion

As of June 2026 Agios Pharmaceuticals has a market cap of HK$13.38 Billion. This makes Agios Pharmaceuticals the world's 5110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$13.38 B5.28%
2025HK$12.71 B-14.03%
2024HK$14.78 B52.12%
2023HK$9.72 B-19.36%
2022HK$12.05 B-13.4%
2021HK$13.91 B-40.17%
2020HK$23.26 B-8.54%
2019HK$25.43 B21%
2018HK$21.02 B-3.47%
2017HK$21.77 B60.17%
2016HK$13.59 B-28.32%
2015HK$18.96 B-41.17%
2014HK$32.24 B456.39%
2013HK$5.79 B

End of Day market cap according to different sources

On Jun 10th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

HK$13.45 Billion
by Nasdaq info icon info icon
HK$13.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.168 T 8,632.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$8.112 T 60,511.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$830.58 B 6,105.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
HK$7.02 B-47.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$105.37 B 687.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$84.11 B 528.50%๐Ÿ‡บ๐Ÿ‡ธ USA